Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564378 · ClinicalTrials.gov registry record
Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure
A clinical trial, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 43
- Enrollment target
NCT04564378 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 43 participants.
The verdict
NCT04564378 has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study is being done to discover if there is a link between estrogen exposure and the severity of Fuchs Endothelial Corneal Disease. We are trying to understand if the decrease in estrogen levels in post-menopausal women may be a reason why FECD is seen more often in women than men.
Interventions
- OTHER This is an observational study. There is no therapeutic intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-01-17 |
| Est. Completion | 2023-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04564378
The ClinicalTrials.gov registry entry for NCT04564378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which This is an observational study. There is no therapeutic intervention. is the first listed.
NCT04564378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04564378 about?
NCT04564378 is a clinical study titled "Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure". This study is being done to discover if there is a link between estrogen exposure and the severity of Fuchs Endothelial Corneal Disease. We are trying to understand if the decrease in estrogen levels in post-menopausal women may be a reason why FECD is seen more often in women than men.
What is the current status of trial NCT04564378?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2018-01-17. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT04564378?
The interventions under investigation include: This is an observational study. There is no therapeutic intervention. (OTHER).
Who is sponsoring clinical trial NCT04564378?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.